References
- Gustafsson G, Garwicz S, Hertz H, et al. A population-based study of childhood acute lymphoblastic leukemia diagnosed from July 1981 through June 1985 in the five Nordic countries. Acta Paediatr Scand. 1987; 76: 781–788
- Harell F. The PHGLM procedure. SAS Supplemental Library User's Guide. SAS Institute Inc, Cary, North CarolinaUSA 1980; 119–131
- Evans AE, Gilbert ES, Zandstra R. The increasing incidence of central nervous system leukemia in children. Cancer 1970; 26: 404–409
- Pinkel D, Simone J, Hustu O, Aur RJA. Nine years experience with “total therapy” of childhood acute lymphocytic leukemia. Pediatrics 1972; 50: 246–260
- Riehm H, Feickert H, Lampert F. Acute lymphoblastic leukemia. Cancer in Children: Clinical Management, PA Voute, A Barret, HJG Bloom, J Lemerle, MK Neidhardt. Springer-Verlag, Heidelberg 1986; 101–118
- Novak L. Radiotherapy of the central nervous system in acute leukemia. Am J Pediatr Hematol Oncol. 1989; 11: 87–92
- Eden OB. CNS minimal disease therapy in childhood leukaemia: the place for irradiation. Br J Cancer 1990; 62: 6–7
- Moe PJ, Seip M, Finne PH, et al. Intermediate dose methotrexate in childhood acute lymphoblastic leukemia. Eur Paediatr Haematol Oncol. 1984; 1: 113–118
- Milano G, Thyss F, Debeauvais S, et al. CSF drug levels for children with acute lymphoblastic leukemia treated with 5 g/m methotrexate. Eur J Cancer 1990; 26: 492–495
- Meadows AT, Baum E, Fossati-Bellani F, et al. Second malignant neoplasms in children: an update from the Late Effects Study Group. J Clin Oncol. 1985; 3: 532–538